Profile data is unavailable for this security.
About the company
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering transformative, precision diagnostics and clinical laboratory services. The Company offers diagnostic testing utilizing proprietary technology to deliver genetics-driven results. It operates through two segments: Real property rental and Lab Services MSO. Lab Services MSO segment is focused on delivering services related to toxicology and wellness testing and provides a portfolio of diagnostic tests including drug testing, toxicology, and a range of test services, from general bloodwork to anatomic pathology, and urine toxicology. Its capabilities include STAT blood testing, qualitative drug screening, genetic testing, urinary testing, and sexually transmitted disease testing. The Lab Services MSO segment is also focused on the commercialization of genetic-based proprietary testing. It is also exploring the commercialization and development of a versatile breathalyzer system, KetoAir breathalyzer.
- Revenue in USD (TTM)1.30m
- Net income in USD-14.54m
- Incorporated2014
- Employees5.00
- LocationAvalon Globocare Corp4400 ROUTE 9, SUITE 3100FREEHOLD 07728United StatesUSA
- Phone+1 (732) 780-4400
- Fax+1 (732) 780-5600
- Websitehttp://www.avalon-globocare.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China Health Management Corp. | 483.00k | -25.60m | 795.23k | 56.00 | -- | -- | -- | 1.65 | -1,378.45 | -1,378.45 | 25.37 | -41.35 | 0.0425 | 1.16 | 1.49 | 8,625.00 | -190.82 | -- | -395.01 | -- | -2,014.49 | -- | -4,486.13 | -- | 0.0203 | -1,353.25 | -- | -- | 37.69 | -- | -363.55 | -- | -- | -- |
| Mitesco Inc | 6.00k | -4.15m | 909.28k | 3.00 | -- | -- | -- | 151.55 | -0.6434 | -0.6121 | 0.0004 | -2.54 | 0.0332 | -- | -- | 2,000.00 | -1,094.48 | -246.54 | -- | -- | 0.00 | -- | -33,009.50 | -29,214.62 | -- | -0.7877 | -- | -- | -- | -- | -59.12 | -- | -- | -- |
| QHSLab Inc | 1.61m | -190.50k | 1.03m | 4.00 | -- | -- | -- | 0.6396 | -0.0199 | -0.0199 | 0.1649 | -0.0367 | 0.9097 | 31.80 | 13.83 | 403,272.50 | -10.74 | -51.17 | -- | -197.31 | 59.52 | -- | -11.81 | -65.10 | 0.1152 | -0.264 | 1.30 | -- | 13.34 | -- | 52.98 | -- | -- | -- |
| IMAC Holdings Inc | 0.00 | -5.63m | 2.38m | 2.00 | -- | -- | -- | -- | -5.04 | -5.46 | 0.00 | -1.08 | 0.00 | -- | 0.00 | 0.00 | -166.65 | -48.88 | -1,050.71 | -70.25 | -- | -- | -- | -97.63 | -- | -14.97 | -- | -- | -- | -- | 45.27 | -- | -- | -- |
| Avalon Globocare Corp | 1.30m | -14.54m | 3.33m | 5.00 | -- | -- | -- | 2.57 | -1.32 | -1.32 | 0.1176 | 0.3839 | 0.0517 | -- | 11.49 | 259,018.00 | -58.06 | -100.94 | -81.85 | -134.51 | 17.21 | 24.44 | -1,122.68 | -1,011.06 | -- | -0.4168 | 0.6497 | -- | 4.45 | -4.28 | -40.03 | -- | -51.83 | -- |
| Medical Care Technologies Inc. | 0.00 | -1.07m | 3.64m | 0.00 | -- | -- | -- | -- | -553,570.10 | -553,570.10 | 0.00 | -389.23 | 0.00 | -- | -- | -- | -154.94 | -- | -- | -- | -- | -- | -- | -- | -- | -1.46 | -- | -- | -- | -- | -40.06 | -- | -- | -- |
| Modern Mobility Aids Inc | 0.00 | -1.59m | 4.58m | -- | -- | -- | -- | -- | -0.0177 | -0.0177 | 0.00 | -0.004 | 0.00 | -- | -- | -- | -4,668.68 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -371.94 | -- | -- | -- |
| Syra Health Corp | 7.07m | -4.19m | 4.69m | 78.00 | -- | 1.51 | -- | 0.6631 | -0.6709 | -0.6709 | 1.19 | 0.3169 | 2.81 | -- | 11.27 | 90,635.38 | -166.37 | -- | -287.17 | -- | 23.56 | -- | -59.23 | -- | -- | -177.32 | 0.0518 | -- | -1.83 | -- | -38.72 | -- | -- | -- |
| CompuMed Inc | 1.78m | -151.00k | 4.87m | 8.00 | -- | 37.44 | -- | 2.74 | -0.1337 | -0.1337 | 1.58 | 0.0997 | 2.38 | 36.71 | 4.83 | -- | -19.92 | -46.77 | -48.38 | -76.78 | 50.42 | 57.04 | -8.38 | -25.84 | 0.9493 | -2.93 | 0.7744 | -- | -1.73 | -5.71 | 64.41 | -- | -18.75 | -- |
| Selectis Health Inc | 37.33m | -6.17m | 4.91m | 574.00 | -- | -- | -- | 0.1315 | -2.02 | -2.02 | 12.19 | -1.05 | 0.8922 | -- | 15.67 | 65,027.49 | -14.67 | -3.03 | -25.30 | -3.58 | -- | -- | -16.44 | -4.84 | -- | -2.98 | 1.11 | -- | -9.40 | 58.97 | -64.93 | -- | -47.72 | -- |
| Holder | Shares | % Held |
|---|---|---|
| HRT Financial LLCas of 30 Jun 2024 | 50.05k | 0.31% |
| UBS Securities LLCas of 30 Jun 2024 | 38.50k | 0.24% |
| Two Sigma Securities LLCas of 30 Jun 2024 | 35.80k | 0.22% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 34.50k | 0.22% |
| Geode Capital Management LLCas of 30 Jun 2024 | 33.16k | 0.21% |
| Millennium Management LLCas of 30 Jun 2024 | 25.38k | 0.16% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 19.12k | 0.12% |
| Citadel Securities LLCas of 30 Jun 2024 | 10.46k | 0.07% |
| Tower Research Capital LLCas of 30 Jun 2024 | 7.16k | 0.05% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 30 Jun 2024 | 200.00 | 0.00% |
